Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes
- Conditions
- Myelodysplastic Syndrome
- Interventions
- First Posted Date
- 2012-05-08
- Last Posted Date
- 2019-05-21
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 9
- Registration Number
- NCT01593670
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer
- Conditions
- Head and Neck CancerHead and Neck Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2012-04-20
- Last Posted Date
- 2019-09-11
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 7
- Registration Number
- NCT01581970
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome
- First Posted Date
- 2012-04-06
- Last Posted Date
- 2018-09-27
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 20
- Registration Number
- NCT01572636
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
- Conditions
- Metastatic Prostate Cancer
- Interventions
- Biological: IndoximodBiological: Sipuleucel-TOther: Placebo
- First Posted Date
- 2012-03-22
- Last Posted Date
- 2020-04-03
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 47
- Registration Number
- NCT01560923
- Locations
- 🇺🇸
University of Illinois Medical Center, Chicago, Illinois, United States
🇺🇸Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
High Dose Chemotherapy and Autologous Transplant for Neuroblastoma
- Conditions
- Neuroblastoma
- Interventions
- Biological: Autologous stem cell infusionBiological: Granulocyte colony stimulating factorRadiation: Radiation therapy
- First Posted Date
- 2012-02-06
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 13
- Registration Number
- NCT01526603
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
- Conditions
- Ewing's Family TumorsRenal TumorsHepatoblastomaRhabdomyosarcomaSoft Tissue SarcomaPrimary Malignant Brain NeoplasmsRetinoblastomaMedulloblastomaSupra-tentorial Primative Neuro-Ectodermal Tumor (PNET)Atypical Teratoid/Rhabdoid Tumor (AT/RT)
- Interventions
- Biological: G-CSFDrug: Anti-seizure prophylaxisBiological: Autologous stem cell infusionProcedure: LeukapheresisRadiation: Radiation
- First Posted Date
- 2012-01-06
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 44
- Registration Number
- NCT01505569
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
T-Cell Depleted Double UCB for Refractory AML
- Conditions
- Acute Myelogenous LeukemiaRefractory Acute Myelogenous Leukemia
- Interventions
- Radiation: Total body irradiationBiological: Umbilical Cord Blood TransplantationBiological: Interleukin-2
- First Posted Date
- 2011-11-03
- Last Posted Date
- 2017-12-28
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 3
- Registration Number
- NCT01464359
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- Conditions
- Lymphatic DiseasesHematopoietic Malignancy
- Interventions
- Biological: Umbilical Cord Blood (UCB)
- First Posted Date
- 2011-10-13
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 250
- Registration Number
- NCT01451502
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma
- Conditions
- Diffuse Intrinsic Pontine Glioma
- Interventions
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2020-03-18
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 8
- Registration Number
- NCT01400672
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
- Conditions
- Acute Myelogenous LeukemiaMyelodysplastic Syndrome
- Interventions
- Drug: Preparative RegimenBiological: Intravenous Recombinant Human IL-15 (rhIL-15)
- First Posted Date
- 2011-06-30
- Last Posted Date
- 2017-12-02
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 26
- Registration Number
- NCT01385423
- Locations
- 🇺🇸
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States